CIK: 0001727492 · Show all filings
Period: Q4 2023 (← Previous) (Next →)
Filing Date: Feb 14, 2024
Total Value ($000): $296,523 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| LQDA | LIQUIDIA CORP | 10,360,945 | $124,642 | 42.0% | $5.57 | +29.2% | COM NEW | 53635D202 |
| — | ALIMERA SCIENCES INC | 16,835,154 | $72,728 | 24.5% | $3.09 | — | COM NEW | 016259202 |
| ANIK | ANIKA THERAPEUTICS INC | 1,081,360 | $24,504 | 8.3% | $26.02 | -20.5% | COM | 035255108 |
| EXEL | EXELIXIS INC | 910,730 | $21,848 | 7.4% | $17.55 | +23.9% | COM | 30161Q104 |
| LAB | STANDARD BIOTOOLS INC | 7,042,413 | $15,564 | 5.2% | $1.23 | +73.4% | COM | 34385P108 |
| EOLS | EVOLUS INC | 1,317,856 | $13,877 | 4.7% | $7.86 | +13.7% | COM | 30052C107 |
| AGIO | AGIOS PHARMACEUTICALS INC | 441,833 | $9,840 | 3.3% | $22.47 | -0.3% | COM | 00847X104 |
| — | Y-MABS THERAPEUTICS INC | 1,048,425 | $7,150 | 2.4% | $6.79 | — | COM | 984241109 |
| — | VERONA PHARMA PLC | 183,064 | $3,639 | 1.2% | $26.13 | — | SPONSORED ADS | 925050106 |
| ADMA | ADMA BIOLOGICS INC | 473,087 | $2,138 | 0.7% | $3.08 | +19.9% | COM | 000899104 |
| — | SOCIETAL CDMO INC | 1,689,768 | $592 | 0.2% | $1.12 | — | COM | 75629F109 |